Literature DB >> 17070994

Expression of C/EBPalpha and C/EBPbeta in glial cells in vitro after inducing glial activation by different stimuli.

Kamil Pérez-Capote1, Josep Saura, Joan Serratosa, Carme Solà.   

Abstract

We studied the involvement of two members of the CCAAT/enhancer binding proteins (C/EBPs) family of transcription factors, C/EBPalpha and C/EBPbeta, in glial activation induced by different stimuli in rat cerebellar neuronal-glial cultures. Glial activation was induced by two types of neuronal death--excitotoxic and apoptotic. We had previously reported that these two induction mechanisms resulted in different patterns of glial activation (K. Pérez-Capote, J. Serratosa, C. Solà, Excitotoxic and apoptotic neuronal death induce different patterns of glial activation in vitro, J. Neurochem. 94 (2005) 226-237), only the former involving an inflammatory response. Glial activation was also induced by lipopolysaccharide (LPS) from E. coli, an inflammatory agent with a known direct effect on glial cells. Using immunocytochemical techniques, here we examined whether changes in C/EBPalpha and C/EBPbeta expression are selectively associated with a determinate pattern of glial activation. Excitotoxic neuronal death increased glial C/EBPbeta expression in the absence of alterations in C/EBPalpha expression, while no effect was observed following neuronal apoptosis. LPS treatment decreased C/EBPalpha and increased C/EBPbeta expression in glial cells. These results implicate C/EBPs in glial activation, although these two factors appear to have different roles. C/EBPalpha expression decreases only in response to LPS, while C/EBPbeta expression is increased by both LPS and excitotoxic neuronal death, although not by neuronal apoptosis. These results show that C/EBPbeta plays an active role in glial activation, but only when this involves an inflammatory reaction, suggesting a role for C/EBPbeta in neuroinflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17070994     DOI: 10.1016/j.neulet.2006.09.078

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

1.  CCAAT/enhancer binding protein delta (CEBPD) elevating PTX3 expression inhibits macrophage-mediated phagocytosis of dying neuron cells.

Authors:  Chiung-Yuan Ko; Ling-Hua Chang; Yi-Chao Lee; Esta Sterneck; Chun-Pei Cheng; Shun-Hua Chen; A-Mei Huang; Joseph T Tseng; Ju-Ming Wang
Journal:  Neurobiol Aging       Date:  2010-11-26       Impact factor: 4.673

2.  Effects of experimental diabetes on C/EBP proteins in rat hippocampus, sciatic nerve and ganglia.

Authors:  Inci Kazkayasi; Nihan Burul-Bozkurt; Sevgen Önder; Pelin Kelicen-Ugur; Can Pekiner
Journal:  Cell Mol Neurobiol       Date:  2013-03-19       Impact factor: 5.046

3.  C/EBPβ/δ-secretase signaling mediates Parkinson's disease pathogenesis via regulating transcription and proteolytic cleavage of α-synuclein and MAOB.

Authors:  Zhourui Wu; Yiyuan Xia; Zhihao Wang; Seong Su Kang; Kecheng Lei; Xia Liu; Lingjing Jin; Xiaochuan Wang; Liming Cheng; Keqiang Ye
Journal:  Mol Psychiatry       Date:  2020-02-21       Impact factor: 15.992

4.  Alcohol alters IL-6 Signal Transduction in the CNS of Transgenic Mice with Increased Astrocyte Expression of IL-6.

Authors:  Donna L Gruol; Claudia Melkonian; Salvador Huitron-Resendiz; Amanda J Roberts
Journal:  Cell Mol Neurobiol       Date:  2020-05-23       Impact factor: 5.046

5.  Inhibition of CD200R1 expression by C/EBP β in reactive microglial cells.

Authors:  Guido Dentesano; Marco Straccia; Aroa Ejarque-Ortiz; Josep M Tusell; Joan Serratosa; Josep Saura; Carme Solà
Journal:  J Neuroinflammation       Date:  2012-07-09       Impact factor: 8.322

6.  Concerted perturbation observed in a hub network in Alzheimer's disease.

Authors:  Dapeng Liang; Guangchun Han; Xuemei Feng; Jiya Sun; Yong Duan; Hongxing Lei
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

7.  Pro-inflammatory gene expression and neurotoxic effects of activated microglia are attenuated by absence of CCAAT/enhancer binding protein β.

Authors:  Marco Straccia; Núria Gresa-Arribas; Guido Dentesano; Aroa Ejarque-Ortiz; Josep M Tusell; Joan Serratosa; Carme Solà; Josep Saura
Journal:  J Neuroinflammation       Date:  2011-11-10       Impact factor: 8.322

8.  Biological roles of CCAAT/Enhancer-binding protein delta during inflammation.

Authors:  Chiung-Yuan Ko; Wen-Chang Chang; Ju-Ming Wang
Journal:  J Biomed Sci       Date:  2015-01-16       Impact factor: 8.410

9.  Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases.

Authors:  Monika Ray; Jianhua Ruan; Weixiong Zhang
Journal:  Genome Biol       Date:  2008-10-08       Impact factor: 13.583

10.  CCAAT-enhancer binding protein-β expression and elevation in Alzheimer's disease and microglial cell cultures.

Authors:  Ron Strohmeyer; Jadd Shelton; Christopher Lougheed; Trisia Breitkopf
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.